Renata B. Hesse, who was head of the Antitrust Division at the Justice Department, is joining Sullivan & Cromwell as a partner in its Washington office, the law firm announced on Monday.
The hiring of Ms. Hesse, 52, is unusual because premier firms like Sullivan & Cromwell rarely hire partners from outside. Typically, they engage newly graduated lawyers who are trained and promoted inside the firm rather than outside its confines.
The hiring comes as many major firms gear up for an increase in complex, cross-border mergers, which are a specialty of Sullivan & Cromwell. Such firms are seeking to become “one-stop shops” for every aspect of mergers in a wide range of industries, including health care, technology, energy, and banking and financial services.
“Renata brings to S.&C. deep and highly relevant government experience, further strengthening our world-class antitrust practice,” said Joseph C.Shenker, chairman of the firm, which has 875 lawyers in New York and elsewhere around the globe. Among its clients are Bayer of Germany in its planned $66 billion acquisition of the American agriculture behemoth Monsanto.
Ms. Hesse, considered a pre-eminent high-technology antitrust attorney, was acting assistant attorney general in charge of the Justice Department’s Antitrust Division until January. She served twice in that position, and she also was deputy assistant attorney general of that division for four years. She was involved in the proposed Comcast and Time Warner Cable merger as well as the merger of US Airways and American Airlines. She also had oversight of the Antitrust Division’s criminal program.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas